http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111533726-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate | 2020-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111533726-B |
titleOfInvention | A kind of preparation method of hematoxylin derivative, its prepared product and its application |
abstract | The invention discloses a preparation method of hematoxylin derivative, the prepared product and application thereof, and relates to the technical field of chemical synthesis. , tert-butyl bromoacetate etherification, ester reduction, hydroxyhalogenation, ethylene glycol etherification and hydrodebenzylation steps to obtain hematoxylin derivative products of hematoxylin-6a-ethylene triacetate; hematoxylin derivatives The preparation method has the advantage of being convenient to expand the application scope of the product; the hematoxylin derivative product has the advantage of expanding the application scope of the product to a certain extent; the hematoxylin derivative product can be used as an active component in the preparation of medicines for the treatment of ischemic cerebral apoplexy or health care In the product, it has the advantage of small dose. |
priorityDate | 2020-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.